Biomaterials Connect

Open Access Policy:
All articles published in the journal Biomaterials Connect are Gold Open Access, immediately available without any embargo period, and licensed under the Creative Commons Attribution 4.0 (CC BY 4.0) license. This license facilitates the unrestricted dissemination of articles, encouraging widespread sharing and utilization of valuable research contributions.

Publication Frequency:
Biomaterials Connect follows a continuous publication model, enabling articles to be published promptly once they have completed the editorial and production process, without waiting for the completion of a full issue. 

Publication Charges:
There will be no article processing charges (APCs) for submissions made by December 31, 2026, and all articles will be published as Open Access. Furthermore, the journal does not levy any additional fees on authors, including editorial processing charges, language editing fees, colour charges, submission fees, membership fees, or any other supplementary charges.

Subject Categories:
Biomaterials Science, Tissue Engineering, Medical Devices

Article Template:
You are encouraged to use the template to format your article according to our guidelines. However, this is not mandatory, as our layout team will ensure all necessary adjustments are made after acceptance and prior to final publication.

Download Template

Target Audience:
This journal is designed for researchers, scientists, engineers, and healthcare professionals dedicated to driving forward the field of biomaterials science.

Ethics Statement:

All articles published by Biomaterials Connect adhere strictly to the ethical guidelines suggested by the Committee on Publication Ethics (COPE).  We execute a stringent peer-review procedure that meticulously assesses the originality, quality, and precision of the research we disseminate. We employ advanced tools to scrutinize the legitimacy of submitted content and maintain a firm zero-tolerance stance toward instances of plagiarism, data manipulation, or inappropriate authorship. For further details, please review our comprehensive Editorial Policies & Ethical Oversight.